Leukaemia Excellence Limited
07041572
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
secretary · Since 16/10/2009
director · Since 19/10/2009
DOCTOR
BRITISH · ENGLAND · Age 60
Also on 1 other board
Persons with Significant Control
Dr Panagiotis Kottaridis
British · England · Age 60
122, St Pancras Way, London, NW1 9NB
Notified 19/10/2016
CompanyRankvs 984+ SIC 86220 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2024
Net Worth
£7.8M
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£2.8M
Working capital
Current Assets
£3.2M
Current Liabilities
£419k
Fixed Assets
£5.0M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 7.71 | +£904k |
| 2023 | 7.86 | +£995k |
| 2022 | 14.05 | +£1.5M |
| 2021 | 18.48 | +£9k |
| 2020 | 10.80 | +£759k |
| 2019 | 9.14 | +£568k |
| 2018 | 8.42 | — |
Derived from filed accounts. Not audited figures.